Series A
Clear all
Showing 22 companies
Altos Labs
Altos Labs
21 jobs
Biotechnology
DeepTech
Health
201 - 1000 employees
Series A

Altos Labs is a biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine. The company comprises a community of leading scientists, clinicians, and leaders from both academia and industry working together towards this common mission. Altos has operations in the San Francisco Bay Area and San Diego, and in Cambridge, UK, with significant collaborations in Japan.

Biotechnology
DeepTech
Manufacturing
51 - 200 employees
Series A

Argonaut provides contract manufacturing for biopharmaceutical, diagnostics and life science organizations. The company's services include high-yield aseptic fill/finish, reagent formulation, filling, kitting, lyophilization, and analytical support. It provides a wide range of diagnostics and drug products for diverse outsourcing needs.

BioRender
BioRender
21 jobs
Biotechnology
DeepTech
Design
Software
201 - 1000 employees
Series A

BioRender is the world's first tool designed to help scientists create and share professional scientific figures quickly and easily. With a library of over 50,000 icons and templates across more than 30 fields of life sciences, BioRender enables users to produce high-quality visuals without requiring any drawing or design skills. The platform is used by over 2.5 million scientists and 1,500 leading institutions, showcasing its strong traction and market position in the science communication space. BioRender's unique offering lies in its intuitive drag-and-drop functionality and customizable templates, making it a go-to solution for researchers looking to effectively communicate their findings.

Biotechnology
DeepTech
Health
11 - 50 employees
Series A

Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation of innovative medicines, including cell and gene therapies.

Biotechnology
DeepTech
Health
11 - 50 employees
Series A

Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions. The company was founded in 2021 and is headquartered in Albuquerque, New Mexico.

Biotechnology
DeepTech
11 - 50 employees
Series A

CRISPR Analytics Platform expands the data and analytics available for CRISPR gene editing, enabling its partners to produce products more quickly. The platform is based on the CRISPR-Chip, a device that is uniquely able to measure CRISPR activity directly.

Biotechnology
Data and Analytics
DeepTech
Health
Software
51 - 200 employees
Series A

Elucidata's proprietary SaaS platform, Polly, transforms drug discovery- one curated dataset at a time. Polly delivers ML-ready biomedical molecular data for accelerated drug discovery. Hosting a rich repository of more than 230,000 multi-omic datasets, Polly curates data semi-automatically, with over 50,000 datasets added each month. The company equips data-driven drug discovery teams with a code-first SaaS platform that integrates proprietary and public biomedical molecular data for ML applications. Inspired by the FAIR guidelines described by the NIH, Polly's Data Lakes allow exclusive access to curated multi-omics data that is ready for ML workflows. Polly offers 10x faster identification of therapeutic assets with high odds of success in the clinic. It has enabled the detection of multiple validated drug targets across immunology, oncology, and metabolomic disorders. Polly supports discovery programs at Pfizer, Agios Pharmaceuticals, Genentech, and Yale and has 35+ research partners from premier biopharma companies and research labs.

Biotechnology
DeepTech
Health
11 - 50 employees
Series A

Enable Medicine is a biotechnology company that accelerates insight discovery by generating, managing, and analyzing spatial biology data on the enable cloud platform. Run experiments, decrease costs, and accelerate time to insight. The Enable Cloud Platform provides a collaborative ecosystem and tools for generating, visualizing, and analyzing many biological image formats. Enable Medicine was established in 2019 by Aaron Mayer and Sunil Bodapati in Menlo Park, California.

Gencove
Gencove
1 jobs
Biotechnology
DeepTech
Health
Professional Services
Software
11 - 50 employees
Series A

Gencove is a pioneering software platform that offers high-throughput, cost-effective genome sequencing through low-pass sequencing technology. Their solutions cater to academic institutions, clinical laboratories, and companies in agriculture and pharmaceuticals, enabling them to obtain complete genomic information efficiently. Gencove differentiates itself by providing a hardware-agnostic service that streamlines genomic data processing, making it accessible for various applications, including human genomics and plant and animal genomics. The company is focused on advancing global health and sustainability by unlocking the value of genetic data, and it has established partnerships with industry leaders to enhance its market position.

Biotechnology
DeepTech
Health
51 - 200 employees
Series A

Haystack Oncology, an oncology company, uses the most recent circulating tumor DNA detection technology to enhance the diagnosis of minimum residual disease and provide superior therapy decision-making information.

Biotechnology
DeepTech
51 - 200 employees
Series A

Moleculent is on a mission to develop technology-enabled products that leverage new insights into the molecular foundation of human biology. Developing amazing products to advance human health gives you purpose. they believe that our understanding of the molecular basis of human biology, in health and disease will increase radically in the coming ten years. This will lead to a vast improvement in therapies, diagnostics, and a new, fundamental understanding

Nodexus
Nodexus
1 jobs
Biotechnology
DeepTech
Health
11 - 50 employees
Series A

Nodexus is a Venture- and SBIR-backed biotech startup commercializing the NX One platform to address widespread unmet needs for accessible live single cell isolation in industrial/biopharma, clinical research, and academic sectors. The NX One platform consists of a low-infrastructure, low-cost hardware system and single-use disposable microfluidic cartridges tailored toward live single-cell workflows involving gene editing (e.g. CRISPR engineering), cell line/antibody development, and tumor heterogeneity studies.